DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
LeMaistre CF, Saleh MN, Kuzel TM. et al.
Phase I trial of a ligand fusion-protein (DAB389IL- 2) in lymphomas expressing the receptor for interleukin- 2
Blood 1998; 91: 399-405
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.